TMCnet - World's Largest Communications and Technology Community



Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of RTI Surgical Holdings, Inc. (RTIX) Investors
[March 24, 2020]

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of RTI Surgical Holdings, Inc. (RTIX) Investors

Glancy Prongay & Murray LLP ("GPM"), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors that purchased RTI Surgical Holdings, Inc. ("RTI Surgical" or "the Company") (NASDAQ: RTIX) securities between March 7, 2016 and March 16, 2020, inclusive (the "Class Period"). RTI Surgical investors have until May 22, 2020 to file a lead plaintiff motion.

If you suffered a loss on your RTI Surgical investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information here or contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, via email or visit our website at to learn more about your rights.

On March 16, 2020, after the market closed, RTI Surgical disclosed that its Audit Committee was investigating "the Company's revenue recognition practices regarding the timing of revenue with respect to certain contractual arrangements, primarily with OEM customers, including the accounting treatment, financial reporting and internal controls related to such arrangements." According to RTI Surgical, the investigation was "precipitated by an ongoing SEC (News - Alert) investigation related to the periods 2014 through 2016."

On this news, the Company's share price fell $0.40, or over 14%, to close at $2.35 per share on March 17, 2020, thereby injuring investors.

The complaint alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose (1) that the Company inappropriately recognized revenues with respect to certain contractual arrangements, including other equipment manufacturer customers; (2) that the Company's internal controls over financial reporting were not effective; (3) that as a result, the Company would be forced to delay the filing of its Form 10-K; (4) as a result of the foregoing, RTI Surgical's public statements were materially false and misleading at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased RTI Surgical securities during the Class Period, you may move the Court no later than May 22, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to, or visit our website at If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

[ Back To's Homepage ]

Technology Marketing Corporation

2 Trap Falls Road Suite 106, Shelton, CT 06484 USA
Ph: +1-203-852-6800, 800-243-6002

General comments:
Comments about this site:


© 2020 Technology Marketing Corporation. All rights reserved | Privacy Policy